Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:25 PM
NCT ID: NCT00986856
Description: All 58 randomised patients comprised the safety analysis set except patients who: 1. did not provide any post randomisation safety data or 2. did not use any trial medication confirmed by return of all trial medication given to the patients.
Frequency Threshold: 0
Time Frame: None
Study: NCT00986856
Study Brief: Fucidin® Cream in the Treatment of Impetigo
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Fucidin® Cream Fucidin® cream 20 mg/g 3 times daily for 10 days None None 0 40 5 40 View
Fucidin® Cream Vehicle Fucidin® cream vehicle 3 times daily for 10 days None None 0 16 4 16 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Gastrointestinal disorders SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA View
Infections and infestations SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA View
Infections and SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA View